3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Obesity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Booij, J; de Bruin, K; Eggels, L; la Fleur, SE; van de Giessen, E; van den Brink, W | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Obesity
Article | Year |
---|---|
High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity.
Topics: Animals; Benzamides; Biological Availability; Contrast Media; Corpus Striatum; Diet; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Dietary Sucrose; Dopamine Antagonists; Energy Intake; Feeding Behavior; Male; Obesity; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |